Evidence map›Paper›PMID 38654330›Full record

ArticleBiotechnology for biofuels and bioproducts2024

Insights into the action of phylogenetically diverse microbial expansins on the structure of cellulose microfibrils.

Majid Haddad Momeni, Aleksi Zitting, Vilma Jäämuru, Rosaliina Turunen, Paavo Penttilä, Garry W Buchko, Salla Hiltunen, Natalia Maiorova, Anu Koivula, Janak Sapkota and 2 more

Open access · goldAbstract read
In one paragraph

Article in Biotechnology for biofuels and bioproducts, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
7.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Reply to Cosgrove: Catalytic activity in expansin-like proteins does not explain wall creep but raises a flag.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. A single-domain expansin-like protein fromProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Majid Haddad MomeniDepartment of Bioproducts and Biosystems, Aalto University, Kemistintie 1, 02150, Espoo, Finland. majid.haddad@aak.com.
Aleksi ZittingDepartment of Bioproducts and Biosystems, Aalto University, Kemistintie 1, 02150, Espoo, Finland.
Vilma JäämuruDepartment of Bioproducts and Biosystems, Aalto University, Kemistintie 1, 02150, Espoo, Finland.
Rosaliina TurunenDepartment of Bioproducts and Biosystems, Aalto University, Kemistintie 1, 02150, Espoo, Finland.
Paavo PenttiläDepartment of Bioproducts and Biosystems, Aalto University, Kemistintie 1, 02150, Espoo, Finland.
Garry W BuchkoEarth and Biological Sciences Directorate, Pacific Northwest National Laboratory, Richland, WA, 99354, USA.
Salla HiltunenNE Research Center, UPM Pulp Research and Innovations, 53200, Lappeenranta, Finland.
Natalia MaiorovaVTT Technical Research Centre of Finland Ltd, P.O. Box 1000, 02044-VTT, Espoo, Finland.
Anu KoivulaVTT Technical Research Centre of Finland Ltd, P.O. Box 1000, 02044-VTT, Espoo, Finland.
Janak SapkotaNE Research Center, UPM Pulp Research and Innovations, 53200, Lappeenranta, Finland.
Kaisa MarjamaaVTT Technical Research Centre of Finland Ltd, P.O. Box 1000, 02044-VTT, Espoo, Finland.
Emma R MasterDepartment of Bioproducts and Biosystems, Aalto University, Kemistintie 1, 02150, Espoo, Finland. emma.master@aalto.fi.
Aalto University · FIVTT Technical Research Centre of Finland · FILappeenranta-Lahti University of Technology · FIUniversity of Toronto · CAWashington State University · US

Funding

Academy of Finland 338804 and 347612European Union's Horizon 2020 964764FICUS program 60027uropean Union - Next Generation EU instrument and the Academy of Finland 347612 (MIMIC)
6 · The paper itself

Abstract

backgroundMicrobial expansins (EXLXs) are non-lytic proteins homologous to plant expansins involved in plant cell wall formation. Due to their non-lytic cell wall loosening properties and potential to disaggregate cellulosic structures, there is considerable interest in exploring the ability of microbial expansins (EXLX) to assist the processing of cellulosic biomass for broader biotechnological applications. Herein, EXLXs with different modular structure and from diverse phylogenetic origin were compared in terms of ability to bind cellulosic, xylosic, and chitinous substrates, to structurally modify cellulosic fibrils, and to boost enzymatic deconstruction of hardwood pulp.

resultsFive heterogeneously produced EXLXs (Clavibacter michiganensis; CmiEXLX2, Dickeya aquatica; DaqEXLX1, Xanthomonas sacchari; XsaEXLX1, Nothophytophthora sp.; NspEXLX1 and Phytophthora cactorum; PcaEXLX1) were shown to bind xylan and hardwood pulp at pH 5.5 and CmiEXLX2 (harboring a family-2 carbohydrate-binding module) also bound well to crystalline cellulose. Small-angle X-ray scattering revealed a 20-25% increase in interfibrillar distance between neighboring cellulose microfibrils following treatment with CmiEXLX2, DaqEXLX1, or NspEXLX1. Correspondingly, combining xylanase with CmiEXLX2 and DaqEXLX1 increased product yield from hardwood pulp by ~ 25%, while supplementing the TrAA9A LPMO from Trichoderma reesei with CmiEXLX2, DaqEXLX1, and NspEXLX1 increased total product yield by over 35%.

conclusionThis direct comparison of diverse EXLXs revealed consistent impacts on interfibrillar spacing of cellulose microfibers and performance of carbohydrate-active enzymes predicted to act on fiber surfaces. These findings uncover new possibilities to employ EXLXs in the creation of value-added materials from cellulosic biomass.

Indexed as

Carbohydrate-active enzymesCelluloseDefibrillationExpansinNon-lytic

Identifiers

PMID38654330
PMCPMC11040781
OpenAlexW4395030349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.